Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108


Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.

Royer-Pokora B, Beier M, Brandt A, Duhme C, Busch M, de Torres C, Royer HD, Mora J.

Cancer Med. 2018 Mar 15. doi: 10.1002/cam4.1379. [Epub ahead of print]


The Effect of Education on Adult Mortality and Health: Evidence from Britain.

Clark D, Royer H.

Am Econ Rev. 2013 Oct;103(6):2087-120.


Nurses' Concerns about Caring for Patients with Acute and Chronic Traumatic Brain Injury.

Oyesanya TO, Bowers BJ, Royer HR, Turkstra LS.

J Clin Nurs. 2018 Feb 5. doi: 10.1111/jocn.14298. [Epub ahead of print]


Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer.

Roßner F, Gieseler C, Morkel M, Royer HD, Rivera M, Bläker H, Dietel M, Schäfer R, Sers C.

Oncogenesis. 2016 Jan 18;5:e187. doi: 10.1038/oncsis.2015.51.


Evaluation of a Curriculum to Improve Clinician Communication With Adolescents.

Olejniczak A, Otalora-Fadner H, Hanna C, Hudson E, Tess J, Royer H.

WMJ. 2015 Oct;114(5):213-6.


Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells.

Pfankuchen DB, Stölting DP, Schlesinger M, Royer HD, Bendas G.

Biochem Pharmacol. 2015 Sep 15;97(2):147-57. doi: 10.1016/j.bcp.2015.07.013. Epub 2015 Jul 31.


Outbreak of psittacosis in a group of women exposed to Chlamydia psittaci-infected chickens.

Laroucau K, Aaziz R, Meurice L, Servas V, Chossat I, Royer H, de Barbeyrac B, Vaillant V, Moyen JL, Meziani F, Sachse K, Rolland P.

Euro Surveill. 2015 Jun 18;20(24). pii: 21155.


Building capacity for the conduct of nursing research at a Veterans Administration hospital.

Phelan CH, Schumacher S, Roiland R, Royer H, Roberts T.

J Nurs Adm. 2015 May;45(5):270-5. doi: 10.1097/NNA.0000000000000197.


Sex and Social Media: New Avenues for Hookups and New Opportunities for Interventions.

Royer HR, Young S, Falk EC.

Adolesc Med State Art Rev. 2014 Dec;25(3):542-52. No abstract available.


The importance of parental knowledge: evidence from weight report cards in Mexico.

Prina S, Royer H.

J Health Econ. 2014 Sep;37:232-47. doi: 10.1016/j.jhealeco.2014.07.001. Epub 2014 Jul 22.


Young women's reasons to seek sexually transmitted infection screening.

Backonja U, Royer HR, Lauver DR.

Public Health Nurs. 2014 Sep-Oct;31(5):395-404. doi: 10.1111/phn.12125. Epub 2014 Apr 28.


Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Busch M, Schwindt H, Brandt A, Beier M, Görldt N, Romaniuk P, Toska E, Roberts S, Royer HD, Royer-Pokora B.

Hum Mol Genet. 2014 Aug 1;23(15):3958-74. doi: 10.1093/hmg/ddu111. Epub 2014 Mar 11.


How liposomal Cisplatin overcomes chemoresistance in ovarian tumour cells.

Stölting DP, Borrmann M, Koch M, Wiese M, Royer HD, Bendas G.

Anticancer Res. 2014 Jan;34(1):525-30.


Liposomal cisplatin can overcome chemotherapy resistance of A2780 ovarian cancer cells by inducing the extrinsic apoptotic pathway.

Stölting DP, Koch M, Wiese M, Royer HD, Bendas G.

Int J Clin Pharmacol Ther. 2014 Jan;52(1):78-81. doi: 10.5414/CPXCES13EA03. No abstract available.


Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities.

van Roeyen CR, Scurt FG, Brandt S, Kuhl VA, Martinkus S, Djudjaj S, Raffetseder U, Royer HD, Stefanidis I, Dunn SE, Dooley S, Weng H, Fischer T, Lindquist JA, Mertens PR.

Cell Commun Signal. 2013 Aug 27;11:63. doi: 10.1186/1478-811X-11-63.


Formative research for the development of an interactive web-based sexually transmitted disease management intervention for young women.

Royer HR, Fernandez-Lambert KM, Moreno MA.

Comput Inform Nurs. 2013 Sep;31(9):430-8. doi: 10.1097/01.NCN.0000432123.79452.32.


Sexually transmitted disease testing misconceptions threaten the validity of self-reported testing history.

Royer HR, Falk EC, Heidrich SM.

Public Health Nurs. 2013 Mar;30(2):117-27. doi: 10.1111/phn.12013. Epub 2012 Nov 22.


Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling.

Koch M, Krieger ML, Stölting D, Brenner N, Beier M, Jaehde U, Wiese M, Royer HD, Bendas G.

Biochem Pharmacol. 2013 Apr 15;85(8):1077-90. doi: 10.1016/j.bcp.2013.01.028. Epub 2013 Feb 8.


Genital herpes beliefs: implications for sexual health.

Royer HR, Falk EC, Heidrich SM.

J Pediatr Adolesc Gynecol. 2013 Apr;26(2):109-16. doi: 10.1016/j.jpag.2012.11.007. Epub 2013 Jan 20.


Cellular response on Auger- and Beta-emitting nuclides: human embryonic stem cells (hESC) vs. keratinocytes.

Fischer T, Sudbrock F, Pomplun E, Kriehuber R, Winkler J, Matzkies M, Dellweg A, Dietlein M, Arnhold S, Royer HD, Schicha H, Hescheler J, Schomäcker K.

Int J Radiat Biol. 2012 Dec;88(12):961-71. doi: 10.3109/09553002.2012.683510. Epub 2012 May 4.


Young women's beliefs regarding human papillomavirus.

Royer HR, Falk EC.

J Obstet Gynecol Neonatal Nurs. 2012 Jan-Feb;41(1):92-102. doi: 10.1111/j.1552-6909.2011.01309.x. Epub 2011 Dec 12.


A Microarray Tool Provides Pathway and GO Term Analysis.

Koch M, Royer HD, Wiese M.

Mol Inform. 2011 Dec;30(11-12):918-21. doi: 10.1002/minf.201100104. Epub 2011 Sep 7.


Young women's Representations of Sexually Transmitted Diseases (RoSTD): a psychometric study.

Royer HR, Heidrich SM, Brown RL.

Res Nurs Health. 2012 Feb;35(1):15-29. doi: 10.1002/nur.21452. Epub 2011 Nov 22.


Sexpectations: male college students' views about displayed sexual references on females' social networking web sites.

Moreno MA, Swanson MJ, Royer H, Roberts LJ.

J Pediatr Adolesc Gynecol. 2011 Apr;24(2):85-9. doi: 10.1016/j.jpag.2010.10.004. Epub 2010 Dec 28.


Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.

Jürchott K, Kuban RJ, Krech T, Blüthgen N, Stein U, Walther W, Friese C, Kiełbasa SM, Ungethüm U, Lund P, Knösel T, Kemmner W, Morkel M, Fritzmann J, Schlag PM, Birchmeier W, Krueger T, Sperling S, Sers C, Royer HD, Herzel H, Schäfer R.

PLoS Genet. 2010 Dec 2;6(12):e1001231. doi: 10.1371/journal.pgen.1001231.


Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.

To K, Fotovati A, Reipas KM, Law JH, Hu K, Wang J, Astanehe A, Davies AH, Lee L, Stratford AL, Raouf A, Johnson P, Berquin IM, Royer HD, Eaves CJ, Dunn SE.

Cancer Res. 2010 Apr 1;70(7):2840-51. doi: 10.1158/0008-5472.CAN-09-3155. Epub 2010 Mar 23.


Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.

Royer-Pokora B, Busch M, Beier M, Duhme C, de Torres C, Mora J, Brandt A, Royer HD.

Hum Mol Genet. 2010 May 1;19(9):1651-68. doi: 10.1093/hmg/ddq042. Epub 2010 Jan 27.


Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.

Krieger ML, Eckstein N, Schneider V, Koch M, Royer HD, Jaehde U, Bendas G.

Int J Pharm. 2010 Apr 15;389(1-2):10-7. doi: 10.1016/j.ijpharm.2009.12.061. Epub 2010 Jan 7.


Young women's beliefs about the terms sexually transmitted disease and sexually transmitted infection.

Royer HR, Cerf C.

J Obstet Gynecol Neonatal Nurs. 2009 Nov-Dec;38(6):686-92. doi: 10.1111/j.1552-6909.2009.01066.x.


Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy.

Gluz O, Mengele K, Schmitt M, Kates R, Diallo-Danebrock R, Neff F, Royer HD, Eckstein N, Mohrmann S, Ting E, Kiechle M, Poremba C, Nitz U, Harbeck N.

J Clin Oncol. 2009 Dec 20;27(36):6144-51. doi: 10.1200/JCO.2008.19.6261. Epub 2009 Nov 9.


NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.

Meis S, Hamacher A, Hongwiset D, Marzian C, Wiese M, Eckstein N, Royer HD, Communi D, Boeynaems JM, Hausmann R, Schmalzing G, Kassack MU.

J Pharmacol Exp Ther. 2010 Jan;332(1):238-47. doi: 10.1124/jpet.109.157750. Epub 2009 Oct 8.


Older breast cancer survivors' symptom beliefs.

Royer HR, Phelan CH, Heidrich SM.

Oncol Nurs Forum. 2009 Jul;36(4):463-70. doi: 10.1188/09.ONF.463-470.


Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells.

Eckstein N, Servan K, Hildebrandt B, Pölitz A, von Jonquières G, Wolf-Kümmeth S, Napierski I, Hamacher A, Kassack MU, Budczies J, Beier M, Dietel M, Royer-Pokora B, Denkert C, Royer HD.

Cancer Res. 2009 Apr 1;69(7):2996-3003. doi: 10.1158/0008-5472.CAN-08-3153. Epub 2009 Mar 24.


Providers' experiences with young people's cognitive representations and emotions related to the prevention and treatment of sexually transmitted infections.

Royer HR, Zahner SJ.

Public Health Nurs. 2009 Mar-Apr;26(2):161-72. doi: 10.1111/j.1525-1446.2009.00767.x.


Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1.

Gosepath EM, Eckstein N, Hamacher A, Servan K, von Jonquieres G, Lage H, Györffy B, Royer HD, Kassack MU.

Int J Cancer. 2008 Nov 1;123(9):2013-9. doi: 10.1002/ijc.23721.


Point-of-use water filtration reduces endemic Pseudomonas aeruginosa infections on a surgical intensive care unit.

Trautmann M, Halder S, Hoegel J, Royer H, Haller M.

Am J Infect Control. 2008 Aug;36(6):421-9. doi: 10.1016/j.ajic.2007.09.012.


The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma.

Chatterjee M, Rancso C, Stühmer T, Eckstein N, Andrulis M, Gerecke C, Lorentz H, Royer HD, Bargou RC.

Blood. 2008 Apr 1;111(7):3714-22. Epub 2007 Nov 15.


Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells.

Eckstein N, Servan K, Girard L, Cai D, von Jonquieres G, Jaehde U, Kassack MU, Gazdar AF, Minna JD, Royer HD.

J Biol Chem. 2008 Jan 11;283(2):739-50. Epub 2007 Oct 17.


Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.

Evers C, Beier M, Poelitz A, Hildebrandt B, Servan K, Drechsler M, Germing U, Royer HD, Royer-Pokora B.

Genes Chromosomes Cancer. 2007 Dec;46(12):1119-28.


Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation.

Grinstein E, Shan Y, Karawajew L, Snijders PJ, Meijer CJ, Royer HD, Wernet P.

J Biol Chem. 2006 Aug 4;281(31):22223-35. Epub 2006 May 12.


Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development.

Glockzin G, Mantwill K, Jurchott K, Bernshausen A, Ladhoff A, Royer HD, Gansbacher B, Holm PS.

J Virol. 2006 Apr;80(8):3904-11.


YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.

Bergmann S, Royer-Pokora B, Fietze E, Jürchott K, Hildebrandt B, Trost D, Leenders F, Claude JC, Theuring F, Bargou R, Dietel M, Royer HD.

Cancer Res. 2005 May 15;65(10):4078-87.


YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.

Stein U, Bergmann S, Scheffer GL, Scheper RJ, Royer HD, Schlag PM, Walther W.

Oncogene. 2005 May 19;24(22):3606-18.


YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders.

Klenova E, Scott AC, Roberts J, Shamsuddin S, Lovejoy EA, Bergmann S, Bubb VJ, Royer HD, Quinn JP.

J Neurosci. 2004 Jun 30;24(26):5966-73.


Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer.

Gessner C, Woischwill C, Schumacher A, Liebers U, Kuhn H, Stiehl P, Jürchott K, Royer HD, Witt C, Wolff G.

Eur Respir J. 2004 Jan;23(1):14-9.


Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy.

Holm PS, Lage H, Bergmann S, Jürchott K, Glockzin G, Bernshausen A, Mantwill K, Ladhoff A, Wichert A, Mymryk JS, Ritter T, Dietel M, Gänsbacher B, Royer HD.

Cancer Res. 2004 Jan 1;64(1):322-8.


YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression.

Jurchott K, Bergmann S, Stein U, Walther W, Janz M, Manni I, Piaggio G, Fietze E, Dietel M, Royer HD.

J Biol Chem. 2003 Jul 25;278(30):27988-96. Epub 2003 Apr 14.


Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection.

Raffetseder U, Frye B, Rauen T, Jürchott K, Royer HD, Jansen PL, Mertens PR.

J Biol Chem. 2003 May 16;278(20):18241-8. Epub 2003 Feb 25.


Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer.

Grinstein E, Wernet P, Snijders PJ, Rösl F, Weinert I, Jia W, Kraft R, Schewe C, Schwabe M, Hauptmann S, Dietel M, Meijer CJ, Royer HD.

J Exp Med. 2002 Oct 21;196(8):1067-78.

Supplemental Content

Support Center